Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2013 Issues
|
Issue 1038
IAC Express: Weekly immunization news and information
Issue 1038: February 5, 2013

TOP STORIES

IAC HANDOUTS

FEATURED RESOURCES

JOURNAL ARTICLES AND NEWSLETTERS

EDUCATION AND TRAINING

CONFERENCES AND MEETINGS



TOP STORIES

Reminder: IAC launched a major redesign of www.vaccineinformation.org, its website for the public
We have completed a major transformation of our website for the public, www.vaccineinformation.org, making it one of the most comprehensive and user-friendly sources of scientifically accurate and easily navigable immunization information on the Web today. Visitors to the website can now easily find what they need, whether they are looking for information on a particular vaccine or on vaccines needed by a particular age group, personal stories or video clips, or other resources, such as those from CDC and state health departments. Titled “Vaccine Information You Need,” the website offers parents, other adults, legislators, the media, and all interested Web users a one-stop shop for learning about vaccines and their importance.

Information on the website is organized into sections based on the four age groups listed below. This arrangement allows visitors to easily find vaccine schedules and other information pertinent to people of a specific age:
Highlights of Vaccineinformation.org
  • Vaccines You Need: Detailed information about the immunization schedules, arranged by age group—infants and children, preteens, teens, and adults
  • Personal Testimonies: Stories of suffering and loss from vaccine-preventable diseases, organized by age group and disease
  • Video Library: Searchable collection of videos and public service announcements about vaccine-preventable diseases and the importance of vaccination
  • Vaccine-Preventable Diseases: Information and resources for all vaccine-preventable diseases, including those associated with international travel
  • Vaccine Basics: Basic and helpful information on vaccines and vaccination, ranging from “Paying for Vaccines” to “How Vaccines Work”
  • Resources: Frequently updated listing of helpful resources, including brochures, blogs, videos, and more, for people in all age groups who seek information about vaccines
Please take a moment to enjoy the colorful experience of “Vaccine Information You Need.” We would love to hear your comments (admin@immunize.org).

If you have a website, blog, or Facebook page, please link to www.vaccineinformation.org.

Back to top


FDA approves expanded age indication for use of Prevnar 13 to include children and teens age 6 through 17 years
On January 25, FDA approved the use of Prevnar 13, the pneumococcal 13-valent conjugate vaccine (PCV13; Pfizer Inc.), for prevention of invasive pneumococcal disease in children and adolescents age 6 through 17 years caused by serotypes contained in the vaccine. Prevnar 13 was originally approved on February 24, 2010, for use in infants and children age 6 weeks through 5 years. On December 30, 2011, FDA approved expanding the age indication for use of Prevnar to include people age 50 and older.

Related Links
Back to top


CDC holds press telebriefing on U.S. adult vaccination rates
On January 29, CDC held a media telebriefing titled U.S. Adult Vaccination Rates. The presenters were Howard Koh, MD, MPH, assistant secretary for health, Department of Health and Human Services, and Carolyn Bridges, MD, associate director of adult immunizations, Immunization Services Division, NCIRD.

Resources for clinicians
Back to top


CDC publishes report on noninfluenza vaccination coverage among U.S. adults in 2011
CDC published Noninfluenza Vaccination Coverage Among Adults—United States, 2011 in the February 1 issue of MMWR (pages 66–72). This report was previously published as an MMWR Early Release on January 29, and was previously covered in the January 29 IAC Express.

Back to top


Clinicians: The Influenza Vaccine Availability Tracking System (IVATS) can help you find influenza vaccine
The National Influenza Vaccine Summit regularly posts updated information to the Influenza Vaccine Availability Tracking System (IVATS). A resource for healthcare settings looking to purchase influenza vaccine, IVATS contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Ongoing updates are being made and will continue to be made throughout the 2012–13 influenza vaccination season. Keep checking back.

Back to top


IAC HANDOUTS

IAC updates its staff-education piece "Pneumococcal Vaccines—CDC answers your questions"
IAC recently made one change to the staff-education piece Pneumococcal Vaccines—CDC answers your questions. The answer to the question summarizing the revaccination recommendations for PPSV23 has been completely rewritten to provide more clarity.

IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.

Back to top


FEATURED RESOURCES

Influenza continues to spread and is serious; vaccination is recommended for nearly everyone, so please keep vaccinating your patients
CDC's recent reports indicate overall elevated influenza activity. Reprinted below is the Key Flu Indicators section of CDC's Summary of Weekly FluView for the week ending January 26.

According to the latest FluView report, while influenza activity remains elevated overall, it is decreasing in parts of the country but increasing in others. In particular, flu activity is declining in the East and increasing in the West of the country. Key indicators reflecting severity, such as hospitalizations and deaths, remain significantly elevated again this week, with the greatest impact occurring among people 65 and older. [IAC Express editor's note: For additional FluView information, see the last entry in the bulleted list below.]

Vaccination remains the single most effective means of preventing influenza. Vaccination is recommended for everyone age 6 months and older, so please continue to vaccinate your patients. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services.

If you are seeking influenza vaccine for your clinic, check the Influenza Vaccine Availability Tracking System (IVATS), which is a resource for healthcare settings looking to purchase influenza vaccine. The IVATS chart contains information from approved, enrolled, and participating wholesale vaccine distributors or manufacturers of U.S. licensed influenza vaccine. Information is updated on an ongoing basis.

Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public.

Back to top


Infographic shows parents how the effectiveness and safety of childhood vaccines are ensured
CDC recently developed an infographic titled The Journey of Your Child's Vaccine. Using words and pictures, it gives parents detailed information on the following:
  • How a new vaccine is developed, approved, and manufactured
  • How a vaccine is added to the U.S. recommended immunization schedule
  • How a vaccine’s safety continues to be monitored
Related Link
A melding of the words Information and graphics, infographics are graphic visual representations of information, data, or knowledge intended to present complex information quickly and clearly. Source: Wikipedia

Back to top


CDC's newly launched Tetanus web section offers information for professionals and the public
Launched in January, CDC's Tetanus web section offers healthcare professionals and the public comprehensive information. Here are links to major topics:
The Tetanus web section home page also offers the public
information on symptoms and tetanus vaccination (what you need to know, vaccine basics, vaccine safety, and school mandates).

Back to top


JOURNAL ARTICLES AND NEWSLETTERS

January issue of CDC's Immunization Works newsletter now available
CDC recently released the January issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely.

The January issue contains a great deal of useful, timely information. Be sure to read through all three sections: News and Summaries; Influenza Information; and Meetings, Conferences, and Resources.

Of particular note, the Meeting, Conferences, and Resources section provides links to the following resources:
Back to top


CDC's QuickStats shows percentage of adults age ≥65 years who ever received pneumococcal vaccine by race/ethnicity
CDC published QuickStats: Percentage of Adults Aged ≥65 Years Who Had Ever Received a Pneumococcal Vaccination, by Selected Race/Ethnicity—National Health Interview Survey, United States, 2000–2011 in the February 1 issue of MMWR (page 75). The figure shows pneumococcal vaccination percentages for white, non-Hispanic; black, non-Hispanic; and Hispanic U.S. adults age 65 and older during the years 2000–2011. The section titled "Alternate Text" is reprinted below.

The figure above shows the percentage of adults aged ≥65 years who had ever received a pneumococcal vaccination, by selected race/ethnicity, in the United States during 2000-2011. The percentage of adults aged ≥65 years who had ever received a pneumococcal vaccination increased from 56.8% in 2000 to 66.5% in 2011 among non-Hispanic whites, from 30.5% in 2000 to 47.6% in 2011 among non-Hispanic blacks, and from 30.4% in 2000 to 43.1% in 2011 among Hispanics. Throughout 2000-2011, the percentage who had ever received a pneumococcal vaccination was higher among non-Hispanic white adults aged ≥65 years than among Hispanics and non-Hispanic blacks.

Back to top


EDUCATION AND TRAINING

February 13 webinar to present CDC's promotional resources for 2013 National Infant Immunization Week
April 20–27 is 2013 National Infant Immunization Week (NIIW). CDC has developed many materials that health departments and others can use to promote NIIW in their communities. CDC will introduce the materials to interested healthcare personnel through a webinar, which is scheduled for February 13 at 1 p.m. ET. Information on other time zones and languages is available.

Use the online registration form to sign up (registration is required).

Online help is available (click on "support" in the left column), as is email assistance
 
Back to top


CDC schedules February 19 webinar on reducing HPV-related cancers through vaccination
A CDC Public Health Grand Rounds webinar titled Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the U.S. will be held February 19 at 1 p.m. ET. 

An archived version of the session will be posted to the Grand Rounds Archive Page within 48–72 hours after the original session is held.

Free continuing education credit is available.

Back to top


CONFERENCES AND MEETINGS

Important: CDC postpones 46th National Immunization Conference until spring 2014
CDC recently announced that the 46th National Immunization Conference (NIC), originally scheduled for June 3–6, 2013, has been postponed until spring 2014. In a message to grantees, CDC stated the following:

Unexpected logistic challenges made it impossible to provide the high quality conference that we have all come to expect so we made the decision to postpone NIC. CDC recognizes the value of NIC and is already engaged in planning for 2014. We will provide the specific dates for the Spring 2014 NIC as soon as we have them.

As we have additional information on the 2014 conference, we will post it on the conference web page and make everyone aware of it. 

IAC Express will inform readers about CDC's plans for the 2014 NIC as they develop.

Back to top


Conference on Options for the Control of Influenza planned for September 5–10 in Cape Town, South Africa
An international scientific conference focused on influenza, Options for Control of Influenza VIII will be held on September 5–10 in Cape Town, South Africa. 

The deadline for abstract submissions is June 3.

Early bird registration ends on February 14. Many online registration options are available.

Back to top



About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104

Copyright (C) 2013 Immunization Action Coalition
All rights reserved.

Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Video: CDC Expert Commentary: Influenza  Antiviral Medications
CDC Expert Commentary: Influenza Antiviral Medications: Influenza is here and early antiviral treatment will help. CDC's Dr. Alicia Fry, medical epidemiologist in the Influenza Division at CDC. offers detailed clinical guidance on the use of antiviral medications in influenza.
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on February 5, 2013
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.